NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Exelixis Inc Share Price Chart

O H L

Exelixis Inc Performance Overview

Days Range
$58.38Low
$59.14High

Markets Today

Previous Close$58.49
Open$58.60
Volume364,753
Day's Range$58.38 - $59.14
52W Range$33.76 - $59.72
Market Cap$14.07 B

Historical Performance

1M Returns+10.11
3M Returns+12.68
6M Returns+41.76
1Y Returns+44.60
5Y Returns+182.29
10Y Returns+328.81

Exelixis Inc Fundamentals

Market Cap$14.07 B
Dividend yield0.00
PE Ratio17.88
PEG RatioN/A
Revenue$2.32 B
ROE TTM0.36
EPS TTM$3.18
Quarterly Earnings Growth YOYN/A
PB Ratio7.66
EBITDA$921.76 M
Profit Margin33.73
Market Cap$14.07 B
Dividend yield0.00
PE Ratio17.88
PEG RatioN/A
Revenue$2.32 B
ROE TTM0.36
EPS TTM$3.18
Quarterly Earnings Growth YOYN/A
PB Ratio7.66
EBITDA$921.76 M
Profit Margin33.73

Exelixis Inc Profit & Loss

Apr 2025Jul 2025Oct 2025Jan 2026Apr 2026Jul 2026
Total Revenue +$555.45 M$568.26 M$597.75 M$598.66 M$610.81 M$628.69 M
Gross Profit +$536.27 M$548.79 M$579.18 M$572.18 M$590.86 M$608.03 M
Operating Income $186.86 M$213.58 M$236.54 M$235.22 M$251.34 M$248.41 M
EBITDA $194.20 M$220.92 M$263.78 M$242.86 M$258.29 M$255.40 M
Interest Expense $0$0$0$0$0$0
Depreciation $7.34 M$7.34 M$27.24 M$7.64 M$6.95 M$6.98 M
Income Before Tax $205.69 M$230.41 M$252.41 M$252.69 M$267.69 M$262.68 M
Income Tax Expense $46.07 M$45.57 M$58.84 M$8.16 M$57.22 M$50.63 M
Net Income +$159.62 M$184.85 M$193.58 M$244.53 M$210.47 M$212.05 M
Net Profit Margin 28.74%32.53%32.38%40.85%34.46%33.73%

Exelixis Inc Financials Balance Sheet In USD

Apr 2025Jul 2025Oct 2025Jan 2026Apr 2026Jul 2026
Share Capital $275.00 K$270.00 K$268.00 K$262.00 K$254.00 K$249.00 K
Reserve & Surplus -$161.28 M-$218.19 M-$102.50 M-$73.35 M-$216.21 M-$264.55 M
Non-Current Liabilities $307.12 M$308.43 M$289.07 M$277.46 M$286.87 M$288.55 M
Current Liabilities $399.10 M$336.11 M$373.78 M$405.64 M$370.98 M$361.93 M
Total Liabilities $706.22 M$644.54 M$662.85 M$683.10 M$657.85 M$650.47 M
Fixed Assets $115.03 M$110.31 M$104.75 M$98.96 M$95.52 M$92.67 M
Current Assets $1.40 B$1.18 B$1.40 B$1.44 B$1.21 B$1.25 B
Total Assets $2.84 B$2.68 B$2.82 B$2.84 B$2.59 B$2.49 B

Exelixis Inc Cash Flow

Apr 2025Jul 2025Oct 2025Jan 2026Apr 2026Jul 2026
Net Income $159.62 M$184.85 M$193.58 M$244.53 M$210.47 M$212.05 M
Operating Cash Flow $211.44 M$48.99 M$290.32 M$333.51 M$251.84 M$307.74 M
Investing Cash Flow $49.76 M$248.03 M$25.41 M$27.24 M-$51.07 M$91.43 M
Financing Cash Flow -$294.82 M-$316.34 M-$103.86 M-$254.57 M-$457.11 M-$343.88 M
Change in Cash -$33.62 M-$19.32 M$211.87 M$106.19 M-$256.34 M$55.30 M

Exelixis Inc Return Calculator

The Exelixis Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$28,050
Invested Amount$10,000
Est. Returns$18,050
Invest in USA Stock Today

About Exelixis Inc

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

FAQs

Exelixis Inc (EXEL) share price as of September 18, 2026 is $58.12. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Exelixis Inc (EXEL) Share by opening an international trading account with Angel One.
Purchasing Exelixis Inc (EXEL) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Exelixis Inc (EXEL) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Exelixis Inc (EXEL) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Exelixis Inc on September 18, 2026, is $14.07 B.
Exelixis Inc operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Exelixis Inc (EXEL) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91